The Protective Effect of Dapagliflozin Against Contrast-Induced Nephropathy After Percutaneous Coronary Catheterization in Patients Moderate to High-Risk for CIN. Vascular and Endovascular Review, [S. l.], v. 8, n. 5s, p. 154–161, 2025. DOI: 10.64149/J.Ver.8.5s.154-161. Disponível em: https://verjournal.com/index.php/ver/article/view/448. Acesso em: 28 apr. 2026.